Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modifier pathways in polyglutamine (PolyQ) diseases: from genetic screens to drug targets
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 79, Issue 5, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-03
DOI
10.1007/s00018-022-04280-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity
- (2020) Mary H. Wertz et al. NEURON
- Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation
- (2020) Surabhi Shukla et al. Frontiers in Pharmacology
- CRISPR-based functional genomics for neurological disease
- (2020) Martin Kampmann Nature Reviews Neurology
- Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease
- (2020) Daniel Zielonka et al. Frontiers in Neurology
- Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders
- (2020) Sujay Paul et al. Cells
- Huntington's disease in the United States: Variation by demographic and socioeconomic factors
- (2019) Emilie Bruzelius et al. MOVEMENT DISORDERS
- The Emerging Role of microRNAs in Polyglutamine Diseases
- (2019) Xiaoyu Dong et al. Frontiers in Molecular Neuroscience
- Three-dimensional modeling of human neurodegeneration: brain organoids coming of age
- (2019) Karl Grenier et al. MOLECULAR PSYCHIATRY
- CRISPR Interference-Based Platform for Multimodal Genetic Screens in Human iPSC-Derived Neurons
- (2019) Ruilin Tian et al. NEURON
- Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein
- (2019) Naila S. Ashraf et al. NEUROBIOLOGY OF DISEASE
- From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
- (2019) Jorge Diogo Da Silva et al. Neurotherapeutics
- Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding
- (2018) Unekwu M. Yakubu et al. BIOLOGICAL CHEMISTRY
- Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
- (2018) Edith L. Pfister et al. HUMAN GENE THERAPY
- CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity
- (2018) Nicholas J. Kramer et al. NATURE GENETICS
- The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease
- (2018) Daniel Zielonka et al. PARKINSONISM & RELATED DISORDERS
- Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3
- (2018) Anna Sergeevna Sowa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration
- (2018) Ismael Al-Ramahi et al. Cell Systems
- Novel Modulators of Proteostasis: RNAi Screen of Chromosome I in a Heat Stress Paradigm in C. elegans
- (2018) Andreas Kern et al. Cells
- Therapeutic approaches to Huntington disease: from the bench to the clinic
- (2018) Nicholas S. Caron et al. NATURE REVIEWS DRUG DISCOVERY
- AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
- (2017) J Miniarikova et al. GENE THERAPY
- Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
- (2017) Ying-Chou Chen et al. MOLECULAR CELL
- Mutant Huntingtin Disrupts the Nuclear Pore Complex
- (2017) Jonathan C. Grima et al. NEURON
- DNAJ Proteins in neurodegeneration: essential and protective factors
- (2017) Christina Zarouchlioti et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- miR-196a Enhances Neuronal Morphology through Suppressing RANBP10 to Provide Neuroprotection in Huntington's Disease
- (2017) Lu-Shiun Her et al. Theranostics
- Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity
- (2016) Marc Brehme et al. Disease Models & Mechanisms
- αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease
- (2016) Ana Osório Oliveira et al. HUMAN MOLECULAR GENETICS
- The S/T-Rich Motif in the DNAJB6 Chaperone Delays Polyglutamine Aggregation and the Onset of Disease in a Mouse Model
- (2016) Vaishali Kakkar et al. MOLECULAR CELL
- Integrated genomics and proteomics define huntingtin CAG length–dependent networks in mice
- (2016) Peter Langfelder et al. NATURE NEUROSCIENCE
- Safety and efficacy of valproic acid treatment in SCA3/MJD patients
- (2016) Li-Fang Lei et al. PARKINSONISM & RELATED DISORDERS
- Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer’s Disease Phenotypes
- (2016) Waseem K. Raja et al. PLoS One
- Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
- (2016) Marta Garcia-Miralles et al. Scientific Reports
- Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity
- (2015) Martin Stroedicke et al. GENOME RESEARCH
- Generation and preclinical characterization of an antibody specific for SEMA4D
- (2015) Terrence L. Fisher et al. mAbs
- siRNA screen identifies QPCT as a druggable target for Huntington's disease
- (2015) Maria Jimenez-Sanchez et al. Nature Chemical Biology
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- MicroRNA-124 slows down the progression of Huntington′s disease by promoting neurogenesis in the striatum
- (2015) Manho Kim et al. Neural Regeneration Research
- Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
- (2015) Amber L. Southwell et al. NEUROBIOLOGY OF DISEASE
- HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements
- (2015) Michal Mielcarek et al. Frontiers in Cellular Neuroscience
- Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo
- (2015) Alex Mas Monteys et al. Molecular Therapy-Nucleic Acids
- The Potential Regulatory Mechanisms of miR-196a in Huntington’s Disease through Bioinformatic Analyses
- (2015) Mu-Hui Fu et al. PLoS One
- Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
- (2015) Sofia Esteves et al. PLoS One
- HspB8 and Bag3: A new chaperone complex targeting misfolded proteins to macroautophagy
- (2014) Serena Carra et al. Autophagy
- Potentiated Hsp104 Variants Antagonize Diverse Proteotoxic Misfolding Events
- (2014) Meredith E. Jackrel et al. CELL
- Large-Scale RNA Interference Screening in Mammalian Cells Identifies Novel Regulators of Mutant Huntingtin Aggregation
- (2014) Tomoyuki Yamanaka et al. PLoS One
- Overexpression of Q-rich prion-like proteins suppresses polyQ cytotoxicity and alters the polyQ interactome
- (2014) Leslie Ripaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteostasis impairment in protein-misfolding and -aggregation diseases
- (2014) Mark S. Hipp et al. TRENDS IN CELL BIOLOGY
- Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
- (2014) Manoj Kumar Mishra et al. Annals of Clinical and Translational Neurology
- miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and Induced Pluripotent Stem Cell Models
- (2013) Pei-Hsun Cheng et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington’s disease
- (2013) Hsin Hsien Yeh et al. BRAIN RESEARCH
- Modeling neurodegenerative diseases in Caenorhabditis elegans
- (2013) Jia Li et al. EXPERIMENTAL NEUROLOGY
- Aggregation formation in the polyglutamine diseases: Protection at a cost?
- (2013) Tiffany W. Todd et al. MOLECULES AND CELLS
- RAS–MAPK–MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1
- (2013) Jeehye Park et al. NATURE
- Glutathione peroxidase activity is neuroprotective in models of Huntington's disease
- (2013) Robert P Mason et al. NATURE GENETICS
- Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance
- (2013) Boxun Lu et al. NATURE NEUROSCIENCE
- MicroRNA-22 (miR-22) Overexpression Is Neuroprotective via General Anti-Apoptotic Effects and May also Target Specific Huntington’s Disease-Related Mechanisms
- (2013) Ana Jovicic et al. PLoS One
- Sodium Valproate Alleviates Neurodegeneration in SCA3/MJD via Suppressing Apoptosis and Rescuing the Hypoacetylation Levels of Histone H3 and H4
- (2013) Jiping Yi et al. PLoS One
- Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis
- (2013) Chaoyun Li et al. REVIEWS IN THE NEUROSCIENCES
- The involvement of microRNAs in neurodegenerative diseases
- (2013) Simona Maciotta et al. Frontiers in Cellular Neuroscience
- Suppression of polyglutamine protein toxicity by co-expression of a heat-shock protein 40 and a heat-shock protein 110
- (2013) Y Kuo et al. Cell Death & Disease
- A network of genes connects polyglutamine toxicity to ploidy control in yeast
- (2013) Christoph J.O. Kaiser et al. Nature Communications
- HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
- (2013) Michal Mielcarek et al. PLOS BIOLOGY
- Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
- (2013) Mimi Cushman-Nick et al. PLoS Genetics
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons
- (2012) François-Xavier Lejeune et al. BMC GENOMICS
- Suppression of protein aggregation by chaperone modification of high molecular weight complexes
- (2012) John Labbadia et al. BRAIN
- Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease
- (2012) Mathuravani A. Thevandavakkam et al. CNS & Neurological Disorders-Drug Targets
- Drosophila Models of Proteinopathies: the Little Fly that Could
- (2012) CURRENT PHARMACEUTICAL DESIGN
- Metazoan Hsp70 machines use Hsp110 to power protein disaggregation
- (2012) Heike Rampelt et al. EMBO JOURNAL
- Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington’s Disease-Like Symptoms in Rats
- (2012) Harikesh Kalonia et al. NEUROTOXICITY RESEARCH
- The influence of gender on phenotype and disease progression in patients with Huntington's disease
- (2012) Daniel Zielonka et al. PARKINSONISM & RELATED DISORDERS
- Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila
- (2012) Hannes Voßfeldt et al. PLoS One
- A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington's Disease
- (2012) John P. Miller et al. PLoS Genetics
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- An integrative approach to ortholog prediction for disease-focused and other functional studies
- (2011) Yanhui Hu et al. BMC BIOINFORMATICS
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans : rescue by the DAF-16 and HSF-1 pathways
- (2011) Andreia Teixeira-Castro et al. HUMAN MOLECULAR GENETICS
- Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1
- (2011) Wing Man Chan et al. HUMAN MOLECULAR GENETICS
- The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: A 2-year follow-up study
- (2011) H. Jacobi et al. NEUROLOGY
- REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
- (2011) Fran Supek et al. PLoS One
- SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
- (2011) Michal Mielcarek et al. PLoS One
- The Mammalian Disaggregase Machinery: Hsp110 Synergizes with Hsp70 and Hsp40 to Catalyze Protein Disaggregation and Reactivation in a Cell-Free System
- (2011) James Shorter PLoS One
- A Genetic Screening Strategy Identifies Novel Regulators of the Proteostasis Network
- (2011) M. Catarina Silva et al. PLoS Genetics
- A Genomewide RNA Interference Screen for Modifiers of Aggregates Formation by Mutant Huntingtin in Drosophila
- (2010) S. Zhang et al. GENETICS
- HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones
- (2010) Michel J. Vos et al. HUMAN MOLECULAR GENETICS
- Loss of Hsp110 Leads to Age-Dependent Tau Hyperphosphorylation and Early Accumulation of Insoluble Amyloid
- (2010) B. Eroglu et al. MOLECULAR AND CELLULAR BIOLOGY
- A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
- (2010) Jurre Hageman et al. MOLECULAR CELL
- Enhanced neuronal RNAi in C. elegans using SID-1
- (2010) Andrea Calixto et al. NATURE METHODS
- Neurodegenerative disorders: Insights from the nematode Caenorhabditis elegans
- (2010) Maria Dimitriadi et al. NEUROBIOLOGY OF DISEASE
- HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3
- (2010) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
- (2009) Eran Eden et al. BMC BIOINFORMATICS
- A Systematic Survey Identifies Prions and Illuminates Sequence Features of Prionogenic Proteins
- (2009) Simon Alberti et al. CELL
- The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease
- (2009) A. N. Packer et al. JOURNAL OF NEUROSCIENCE
- Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease
- (2009) J. L. Wacker et al. JOURNAL OF NEUROSCIENCE
- Progression of ataxia in patients with Machado-Joseph disease
- (2009) Marcondes C. França et al. MOVEMENT DISORDERS
- The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation
- (2009) Stephen Tam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
- (2009) Dénes Zádori et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- RNAi Screening in Drosophila Cells Identifies New Modifiers of Mutant Huntingtin Aggregation
- (2009) Joanna Doumanis et al. PLoS One
- Nuclear accumulation of polyglutamine disease proteins and neuropathology
- (2009) Lauren S Havel et al. Molecular Brain
- Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
- (2008) Christophe Lo Bianco et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis
- (2008) Yoontae Lee et al. NATURE NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search